About Evergreen Nephrology
Evergreen Nephrology is a company based in Nashville (United States) founded in 2021 by Matt Kim and Abe Sutton.. Evergreen Nephrology has raised $130 million across 1 funding round from investors including Rubicon Founders, Oak HC/FT and K2 HealthVentures. Evergreen Nephrology offers products and services including Kidney Care Services. Evergreen Nephrology operates in a competitive market with competitors including Pathalys, AdaptX, Bial, Iris Plans and Specialty Networks, among others.
- Headquarter Nashville, United States
- Founders Matt Kim, Abe Sutton
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Evergreen Nephrology, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$130 M (USD)
in 1 rounds
-
Latest Funding Round
$130 M (USD), Series D
Jan 16, 2025
-
Investors
Rubicon Founders
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Evergreen Nephrology
Evergreen Nephrology offers a comprehensive portfolio of products and services, including Kidney Care Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology-enabled tools for nephrologists to manage and improve kidney disease care
Unlock access to complete
Funding Insights of Evergreen Nephrology
Evergreen Nephrology has successfully raised a total of $130M through 1 strategic funding round. The most recent funding activity was a Series D round of $130 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series D — $130.0M
-
First Round
First Round
(16 Jan 2025)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2025 | Amount | Series D - Evergreen Nephrology | Valuation | Rubicon Founders , Oak HC/FT |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Evergreen Nephrology
Evergreen Nephrology has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Rubicon Founders, Oak HC/FT and K2 HealthVentures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investment firm focused on building transformational companies.
|
Founded Year | Domain | Location | |
|
Investments are made in early-stage healthtech and fintech startups.
|
Founded Year | Domain | Location | |
|
Flexible, long-term financing solutions are provided to healthcare companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Evergreen Nephrology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Evergreen Nephrology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Evergreen Nephrology Comparisons
Competitors of Evergreen Nephrology
Evergreen Nephrology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pathalys, AdaptX, Bial, Iris Plans and Specialty Networks, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biotherapeutics for chronic kidney disease are developed and provided.
|
|
| domain | founded_year | HQ Location |
Clinical management solutions are provided for healthcare by AdaptX.
|
|
| domain | founded_year | HQ Location |
Develops and commercializes pharmaceutical products through research and global distribution.
|
|
| domain | founded_year | HQ Location |
Offers comprehensive health care planning through consultations and document creation services.
|
|
| domain | founded_year | HQ Location |
Specialty Networks is focused on supporting independent specialty healthcare providers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Evergreen Nephrology
Frequently Asked Questions about Evergreen Nephrology
When was Evergreen Nephrology founded?
Evergreen Nephrology was founded in 2021 and raised its 1st funding round 4 years after it was founded.
Where is Evergreen Nephrology located?
Evergreen Nephrology is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
Is Evergreen Nephrology a funded company?
Evergreen Nephrology is a funded company, having raised a total of $130M across 1 funding round to date. The company's 1st funding round was a Series D of $130M, raised on Jan 16, 2025.
What does Evergreen Nephrology do?
Evergreen Nephrology was founded in 2021 in Nashville, United States, by co-founders Matt Kim and Abe Sutton. Operations are centered in the healthcare sector, with a focus on nephrology. Chronic care management services for patients with kidney diseases are delivered through coordinated medical support and monitoring. The company serves individuals requiring ongoing treatment for renal conditions, based in the United States.
Who are the top competitors of Evergreen Nephrology?
What products or services does Evergreen Nephrology offer?
Evergreen Nephrology offers Kidney Care Services.
Who are Evergreen Nephrology's investors?
Evergreen Nephrology has 3 investors. Key investors include Rubicon Founders, Oak HC/FT, and K2 HealthVentures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.